These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

726 related items for PubMed ID: 24675279

  • 1. Doxorubicin-conjugated core-shell magnetite nanoparticles as dual-targeting carriers for anticancer drug delivery.
    Sadighian S, Rostamizadeh K, Hosseini-Monfared H, Hamidi M.
    Colloids Surf B Biointerfaces; 2014 May 01; 117():406-13. PubMed ID: 24675279
    [Abstract] [Full Text] [Related]

  • 2. Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug.
    Sahoo B, Devi KS, Banerjee R, Maiti TK, Pramanik P, Dhara D.
    ACS Appl Mater Interfaces; 2013 May 01; 5(9):3884-93. PubMed ID: 23551195
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Preparation and characterization of magnetic gold nanoparticles to be used as doxorubicin nanocarriers.
    Elbialy NS, Fathy MM, Khalil WM.
    Phys Med; 2014 Nov 01; 30(7):843-8. PubMed ID: 24950615
    [Abstract] [Full Text] [Related]

  • 5. Facile Layer-by-Layer Self-Assembly toward Enantiomeric Poly(lactide) Stereocomplex Coated Magnetite Nanocarrier for Highly Tunable Drug Deliveries.
    Li Z, Yuan D, Jin G, Tan BH, He C.
    ACS Appl Mater Interfaces; 2016 Jan 27; 8(3):1842-53. PubMed ID: 26717323
    [Abstract] [Full Text] [Related]

  • 6. Synthesis of Cross-linked Poly (N-isopropylacrylamide) Magnetic Nano Composite for Application in the Controlled Release of Doxorubicin.
    Kaamyabi S, Badrian A, Akbarzadeh A.
    Pharm Nanotechnol; 2017 Jan 27; 5(1):67-75. PubMed ID: 28948911
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Rapamycin loaded magnetic Fe3O4/carboxymethylchitosan nanoparticles as tumor-targeted drug delivery system: Synthesis and in vitro characterization.
    Li G, Cao L, Zhou Z, Chen Z, Huang Y, Zhao Y.
    Colloids Surf B Biointerfaces; 2015 Apr 01; 128():379-388. PubMed ID: 25779605
    [Abstract] [Full Text] [Related]

  • 12. The enzyme-sensitive release of prodigiosin grafted β-cyclodextrin and chitosan magnetic nanoparticles as an anticancer drug delivery system: Synthesis, characterization and cytotoxicity studies.
    Rastegari B, Karbalaei-Heidari HR, Zeinali S, Sheardown H.
    Colloids Surf B Biointerfaces; 2017 Oct 01; 158():589-601. PubMed ID: 28750341
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Improvement of Anticancer Drug Release by Cobalt Ferrite Magnetic Nanoparticles through Combined pH and Temperature Responsive Technique.
    Dey C, Ghosh A, Ahir M, Ghosh A, Goswami MM.
    Chemphyschem; 2018 Nov 05; 19(21):2872-2878. PubMed ID: 30133086
    [Abstract] [Full Text] [Related]

  • 15. Anticancer medicines (Doxorubicin and methotrexate) conjugated with magnetic nanoparticles for targeting drug delivery through iron.
    Samra ZQ, Ahmad S, Javeid M, Dar N, Aslam MS, Gull I, Ahmad MM.
    Prep Biochem Biotechnol; 2013 Nov 05; 43(8):781-97. PubMed ID: 23876138
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Investigation of novel superparamagnetic Ni0.5Zn0.5Fe2O4@albumen nanoparticles for controlled delivery of anticancer drug.
    Qasim M, Asghar K, Dharmapuri G, Das D.
    Nanotechnology; 2017 Sep 08; 28(36):365101. PubMed ID: 28675377
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Synthesis and characterisation of a pH-sensitive magnetic nanocomposite for controlled delivery of doxorubicin.
    Xu SS, Wu J, Jiang W.
    J Microencapsul; 2015 Sep 08; 32(6):533-7. PubMed ID: 26289219
    [Abstract] [Full Text] [Related]

  • 20. Release of a liver anticancer drug, sorafenib from its PVA/LDH- and PEG/LDH-coated iron oxide nanoparticles for drug delivery applications.
    Ebadi M, Bullo S, Buskara K, Hussein MZ, Fakurazi S, Pastorin G.
    Sci Rep; 2020 Dec 09; 10(1):21521. PubMed ID: 33298980
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.